What are the "highs" and "lows" of cannabis legalization in Canada?
From rising cases of psychosis and a puzzling vomiting syndrome to the struggle of spreading accurate public health messages, we unpack the real-world health effects of legalization — made in Canada.
Please note, this podcast was recorded before the holidays, which is why we refer to holiday dinners in one of our questions.
Our guest:
Dr. Daniel Myran is a public health and family medicine physician and researcher. He holds the Canada Research Chair in Social Accountability at the University of Ottawa, and is an ICES Adjunct Scientist, Investigator at the Bruyère Health Research Institute, and a Clinician Investigator at The Ottawa Hospital. His program of research involves using health administrative data to examine the burden and societal impact of mental health conditions and substance use. Dr. Myran’s primary focus is examining the health impacts of changes in alcohol/cannabis and drug policies and their influence on health inequities. As a secondary area of interest, he uses big data to examine the health of physicians and their practice patterns.
Read the research from Dr. Myran:
Read the Op‐Ed: There are good reasons to be anxious about growing cannabis use in Canada - The Globe and Mail
2. Emergency department visits involving hallucinogen use and risk of schizophrenia spectrum disorder
5. Unintentional pediatric poisonings before and during the COVID-19 pandemic: a population-based study
EPISODE CREDITS:
Produced, edited and mixed by Will Mcintyre, Richard Villeneuve and Pop Up Podcasting
Artwork designed by Stella-Luna Ha
Music licensed through Melodie Music
LINKS:
Be sure to follow and tag ICES on Bluesky, X, Instagram and LinkedIn. To find out more about our organization, visit us at ices.on.ca
